300583 Stock Overview
Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid biomedicine intermediates.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Shandong Sito Bio-technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.75 |
| 52 Week High | CN¥23.84 |
| 52 Week Low | CN¥11.94 |
| Beta | 0.21 |
| 1 Month Change | -25.53% |
| 3 Month Change | -25.74% |
| 1 Year Change | -17.04% |
| 3 Year Change | -9.85% |
| 5 Year Change | -41.58% |
| Change since IPO | -64.84% |
Recent News & Updates
Shareholder Returns
| 300583 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -10.5% | -1.5% | -0.4% |
| 1Y | -17.0% | -16.0% | -17.6% |
Return vs Industry: 300583 underperformed the CN Pharmaceuticals industry which returned -15.9% over the past year.
Return vs Market: 300583 matched the CN Market which returned -17.8% over the past year.
Price Volatility
| 300583 volatility | |
|---|---|
| 300583 Average Weekly Movement | 9.4% |
| Pharmaceuticals Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 300583's share price has been volatile over the past 3 months.
Volatility Over Time: 300583's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 1,317 | Lianbiao Jin | www.sitobiotech.com |
Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid biomedicine intermediates. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tetraene, androstenedione, ketal, 3-ketal, norandrostenedione, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.
Shandong Sito Bio-technology Co., Ltd. Fundamentals Summary
| 300583 fundamental statistics | |
|---|---|
| Market cap | CN¥2.42b |
| Earnings (TTM) | CN¥61.83m |
| Revenue (TTM) | CN¥1.30b |
39.1x
P/E Ratio1.9x
P/S RatioIs 300583 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300583 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.30b |
| Cost of Revenue | CN¥1.04b |
| Gross Profit | CN¥266.18m |
| Other Expenses | CN¥204.35m |
| Earnings | CN¥61.83m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 20.44% |
| Net Profit Margin | 4.75% |
| Debt/Equity Ratio | 40.2% |
How did 300583 perform over the long term?
See historical performance and comparison